½ÃÀ庸°í¼­
»óǰÄÚµå
1402593

¾à¹°³²¿ë Ä¡·á ½ÃÀå : ³²¿ë À¯Çüº°, ¾à¹° À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°

Drug Abuse Treatment Market, By Abuse Type, By Drug Type, By Distribution Channel, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀåÀº 2023³â 357¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2030³â 207¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 8.1%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2022³â 2023³â ½ÃÀå ±Ô¸ð 207¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£ÀÇ CAGR 8.10% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 357¾ï 4,000¸¸ ´Þ·¯
±×¸² 1. ¾à¹°³²¿ë Ä¡·á ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Drug Abuse Treatment Market- IMG1

¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀåÀº ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ·Î ºÒ¹ý ¾à¹°¿¡ ´ëÇÑ Á¢±ÙÀÌ ¿ëÀÌÇØÁü¿¡ µû¶ó ¾à¹°³²¿ë Àå¾ÖÀÇ À¯º´·üÀÌ Áõ°¡Çϰí Á¤½Å °Ç°­ ¹®Á¦°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, Áßµ¶ Ä¡·á¸¦ À§ÇÑ ´Ù¾çÇÑ ¾à¸®ÇÐÀû, ½É¸®Àû Ä¡·á¹ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Àü¹®°¡ÀÇ µµ¿òÀ» ¿äûÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³ª°í ÀÖ½À´Ï´Ù. ¾à¹°³²¿ë¿¡ ´ëÇÑ °Ç°­º¸Çè Àû¿ë ¹üÀ§ È®´ë¿Í ÇÔ²² Ä¡·á ÇÁ·Î±×·¥À» Àå·ÁÇÏ´Â Á¤ºÎÀÇ ´Ù¾çÇÑ ³ë·Âµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾à¹° Áßµ¶°ú °ü·ÃµÈ »çȸÀû ³«ÀÎ(½ºÆ¼±×¸¶)Àº ¿©ÀüÈ÷ ¸¹Àº ȯÀÚµéÀÌ °¡´ÉÇÑ Ä¡·á ¿É¼ÇÀ» Àû±ØÀûÀ¸·Î Ãß±¸ÇÏÁö ¸øÇϵµ·Ï ¸·°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀåÀº ÁÖ·Î Àü ¼¼°è ¾à¹°³²¿ë Àå¾ÖÀÇ È®»ê¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ÃßÁ¤¿¡ µû¸£¸é, 2023³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 3,100¸¸ ¸í ÀÌ»óÀÌ ¾à¹° »ç¿ë Àå¾Ö¸¦ ¾Î°í ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¶¾à ¹Ð¸Å ³×Æ®¿öÅ©ÀÇ ¹ø¿µ°ú »çȸÀû ¼ö¿ë¼º Áõ°¡·Î ÀÎÇØ ¸¶¾àÀ» ½±°Ô ±¸ÇÒ ¼ö ÀÖ°Ô µÈ °ÍÀÌ ¼ÒºñÀ² Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ì¿ïÁõ°ú ºÒ¾ÈÁõ°ú °°Àº Á¤½Å °Ç°­ ¹®Á¦ÀÇ Áõ°¡·Î ÀÎÇØ °³ÀεéÀÌ ¾à¹° ÀÇÁ¸¿¡ ºüÁö´Â °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ´Â Ä¡·á Á¦°øÀÚ¿¡°Ôµµ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÄÚÄ«ÀÎ, ¾ËÄÚ¿Ã, ¿ÀÇÇ¿ÀÀ̵å, ´ë¸¶ÃÊ Áßµ¶¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ´Ù¾çÇÑ ¾à¸®ÇÐÀû, ½É¸®Àû Ä¡·á¹ýµµ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ¸¹Àº ȯÀڵ鿡°Ô ¿Ü·¡ ÀçȰ ÇÁ·Î±×·¥Àº ºñ¿ëÀÌ ¸¹ÀÌ µé±â ¶§¹®¿¡ °æÁ¦ÀûÀÎ Á¦¾àÀÌ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀϺΠÁö¿ª¿¡¼­´Â »çȸÀû Áö¿øÀÇ ºÎÁ·µµ ¼º°øÀûÀΠȸº¹¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí, À¯¸®ÇÑ ±ÔÁ¦¿Í ÀÎ½Ä °³¼± Ä·ÆäÀÎÀ» ÅëÇÑ Á¤ºÎÀÇ Áö¿øÀº ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â 2022³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR %)À» Á¦½ÃÇÏ´Â ¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×µµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ¾à¹°³²¿ë Ä¡·á ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ½Å±Ô ÀǾàǰÀÇ °³¹ß
    • ¾à¹°³²¿ë¿¡ µû¸¥ »çȸÀû Æí°ß
    • ½ÃÀå °ü°èÀÚ°£ Àü·«Àû Çù·Â
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÃÖ±ÙÀÇ µ¿Çâ
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porters ºÐ¼®
  • ÇÕº´, Àμö ¹× Çù¾÷

Á¦4Àå ¼¼°èÀÇ ¾à¹°³²¿ë Ä¡·á ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾à¹°³²¿ë Ä¡·á ½ÃÀå, ³²¿ë À¯Çüº°, 2018-2030³â

  • ¾ËÄÚ¿Ã Áßµ¶
  • ´ã¹è/´ÏÄÚÆ¾ Áßµ¶
  • ¿ÀÇÇ¿ÀÀ̵å Áßµ¶

Á¦6Àå ¼¼°èÀÇ ¾à¹°³²¿ë Ä¡·á ½ÃÀå, ¾à¹° À¯Çüº°, 2018-2030³â

  • µð¼³ÇǶ÷
  • ¾ÆÄ¯ÇÁ·Î¼¼ÀÌÆ®
  • ³¯Æ®·º¼Õ
  • ¸ÞŸµ·
  • ºÎÇÁ·¹³ë¸£ÇÉ
  • ´ÏÄÚÆ¾ Áßµ¶ Ä¡·á
  • ´ÏÄÚÆ¾ ´ëü Ä¡·á
  • ºñ´ÏÄÚÆ¾¾à
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¾à¹°³²¿ë Ä¡·á ½ÃÀå, À¯Åë ä³Îº°, 2018-2030³â

  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹

Á¦8Àå ¼¼°èÀÇ ¾à¹°³²¿ë Ä¡·á ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • µ¶ÀÏ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • ASEAN
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan NV
    • Odyssey Pharmaceuticals Inc.
    • Lil'Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics

Á¦10Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
ksm 24.01.12

Global drug abuse treatment market is expected to reach US$ 20.70 Bn by 2030, from US$ 35.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 20.70 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.10% 2030 Value Projection: US$ 35.74 Bn
Figure 1. Global Drug Abuse Treatment Market Share (%), By Region, 2023
Drug Abuse Treatment Market - IMG1

Global drug abuse treatment market has been witnessing significant growth in the recent years. Rising prevalence of substance abuse disorders mainly due to easy availability of illicit drugs and growing mental health issues have necessitated effective treatment options. Moreover, increasing awareness about various pharmacological and psychological therapies for addiction treatment is driving more individuals to seek professional help. Various government initiatives promoting treatment programs along with growing health insurance coverage for substance abuse are also fueling the market expansion. However, social stigma associated with drug addiction continues to deter many patients from actively pursuing the available treatment options.

Market Dynamics:

Global drug abuse treatment market is primarily driven by growing substance abuse disorder prevalence worldwide. According to recent estimates, over 31 Mn people globally suffer from substance use disorders in 2023. Easy accessibility of drugs due to flourishing trafficking networks and rising social acceptance has resulted in higher consumption rates. Moreover, increasing mental health problems such as depression and anxiety often lead individuals towards substance dependency, thereby benefitting treatment providers. Various pharmacological and psychological therapies available for cocaine, alcohol, opioid, and cannabis addiction are also boosting the demand. However, financial constraints constitute a major restraint with outpatient rehab programs being costly for many patients. Lack of social support also acts as an impediment for successful recovery in a few regions. Nonetheless, government support through favorable regulations and public awareness campaigns present lucrative opportunities for sustained market growth.

Key features of the study:

  • This report provides in-depth analysis of the global drug abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global drug abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., and British American Tobacco Plc., Alkermes, Sun Pharmaceuticals, Dr. Reddy's Laboratories, BioCorRx, Inc., DXC Technology Company, and GenoLogics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug abuse treatment market

Detailed Segmentation:

  • Global Drug Abuse Treatment Market, By Abuse Type
    • Alcohol Dependence
    • Tobacco/Nicotine Addiction
    • Opioid Addiction
  • Global Drug Abuse Treatment Market, By Drug Type
    • Disulfiram
    • Acamprosate
    • Naltrexone
    • Methadone
    • Buprenorphine
    • Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
    • Non-Nicotine Medication
    • Bupropion
    • Varenicline
    • Others
  • Global Drug Abuse Treatment Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Drug Abuse Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Global Drug Abuse Treatment Market:
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Abuse Type
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet ,By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Novel drug development
    • Social stigma associated with drug abuse
    • Strategic collaboration between market players
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Drug Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Abuse Treatment Market, By Abuse Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Alcohol Dependence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Tobacco/Nicotine Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Opioid Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Drug Abuse Treatment Market, By Drug Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Disulfiram
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acamprosate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Naltrexone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Methadone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Buprenorphine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Addiction Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
  • Non-Nicotine Medication
    • Bupropion
    • Varenicline
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Drug Abuse Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Drug Abuse Treatment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profile
    • Cipla Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦